Loading...
Loading...
Analysts at Goldman Sachs upgraded Boston Scientific
BSX from Sell to Neutral.
The price target for Boston Scientific has been raised from $11.00 to $13.00.
Boston Scientific shares have gained 6.76% over the past 52 weeks, while the S&P 500 index has surged 9.99% in the same period.
Boston Scientific's shares closed at $12.32 in after-hours trading.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in